Alaunos Therapeutics, Inc. (TCRT) Total assets 2016–2025
Alaunos Therapeutics, Inc. (TCRT) total assets at each fiscal year-end, per SEC filings.
$3.0MFY2025 · since FY2016: $106.3M → $3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.0M | +7.7% |
| FY2024 | $2.8M | -66.7% |
| FY2023 | $8.3M | -87.3% |
| FY2022 | $64.9M | -31.5% |
| FY2021 | $94.9M | -35.2% |
| FY2020 | $146.3M | — |
| FY2018 | $95.1M | -10.0% |
| FY2017 | $105.6M | -0.7% |
| FY2016 | $106.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TCRT financial trends
TCRT RevenueTCRT Net incomeTCRT Net marginTCRT Gross profitTCRT Gross marginTCRT Operating incomeTCRT Operating marginTCRT Operating cash flowTCRT Free cash flowTCRT Capital expendituresTCRT Return on equityTCRT Stock buybacksTCRT Dividends paidTCRT Total liabilitiesTCRT Shareholders’ equityTCRT overview →